---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-003742"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2026-07-31T20:06:33+00:00"
generated_at: "2026-07-31T20:08:04.248351+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Amnon Peled resigns from Silexion Therapeutics board effective August 1, 2026

## Summary
- Professor Amnon Peled resigned from the Board of Directors for personal reasons, effective August 1, 2026.
- Resignation did not result from any disagreement with the Company on operations, policies, or practices.
- No replacement director has been announced as of the filing date.

## SEC filing metadata
- accession: 0001178913-26-003742
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2026-07-31T20:06:33+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891326003742/0001178913-26-003742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891326003742/zk2635801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-003742
- JSON: https://secwatch.observer/filing/0001178913-26-003742.json
- Plain text: https://secwatch.observer/filing/0001178913-26-003742.txt

## Key facts
- Executive change
  Amnon Peled resigned as Director at Silexion Therapeutics Corp.
  - Action: resigned
  - Role: Director
  source text: On July 30, 2026, Professor Amnon Peled notified the Board of Directors (the “ Board ”) of Silexion Therapeutics Corp (the “ Company ”) of his resignation from his position as a member of the Board, for personal reasons, effective as of August 1, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2022416/000117891326003742/0001178913-26-003742-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.